Sunapten Therapeutics

Description

• Sunapten Therapeutics is a Michigan-based, early stage, pharmaceutical company which is developing an innovative approach to stimulating immune responses against tumor antigens and pathological proteins in a wide range of immuno-inflammatory and infectious diseases. The company has filed patents describing proprietary immunological methods of inducing antibody responses against self proteins and poorly immunogenic foreign proteins.We use a novel, proprietary and patentable method of making target proteins appearforeign to the immune system and thereby break immune tolerance. Sunaptens novel technology can be applied to proteins on the surface of cancer cells and pathological proteins expressed in numerousdisorders including autoimmune and inflammatory diseases. This combines the advantages of small molecule drugs, biologics, and vaccines.Platform OpportunitiesThe same innovative concept used to produce a prostate cancer vaccine can be applied to other cancer types (renal, breast, colorectal cancers), as well chronic inflammatory diseases (rheumatoid arthritis, asthma), and infectious diseases (malaria, HIV). This innovative approach to drug discovery will provide Sunapten Therapeutics with an opportunity for tremendous growth and expansion into multiple therapeutic areas with unmet medical needs.
• 

  Headquarters:4717 Campus Drive , Kalamazoo, Michigan, United States

  More
• 

  Phone Number: +1 269-372-8732

• 

  Website: https://www.sunapten.com

• 

  Employees:1

• 

  Revenue:$1 - 10M

• 

  Legal Name:Sunapten Therapeutics

• Sunapten Therapeutics's Social Media

  
• Is this data correct?

• |  NAICS Code: 541713  |

  Show More